Getting abortion pills through the mail is safe, quick, and effective, study finds; Galapagos, in makeover mode, strikes deal to make CAR-T therapies at blood centers across U.S.

Taking stock of the drug industry, from the lab to the medicine chest

May 15, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Allen G. Breed/AP STAT+ | Getting abortion pills through the mail is safe, quick, and effective, study finds "Mifepristone should be treated like every other medication," said Daniel Grossman, a professor at the University of California, San Francisco. By Ed Silverman STAT+ | Galapagos, in makeover mode, strikes deal to make CAR-T therapies at blood centers across U.S. Galapagos said the collaboration could help overcome the limitations that have held back access to CAR-T therapies from other companies. By Andrew Joseph Opinion: Cutting-edge insulin is good. But it's the 'trailing edge' of older versions that can keep it affordable When pharma companies "discontinue" older forms of insulin, prices generally rise and it becomes more difficult to make generic versions. By Robin Feldman

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser